An Overview of JASCAYD® (nerandomilast) tablets for the Clinician - An Interactive Learning Theater

ATS Conference News

May 15-20 | Orlando, Fl

We help the world breathe.

Industry Connections With Boehringer Ingelheim

Sponsored Content

The following content is part of a paid sponsorship and is not an endorsement by the American Thoracic Society nor does it reflect the views or opinions of the American Thoracic Society.

An Overview of JASCAYD® (nerandomilast) tablets for the Clinician – An Interactive Learning Theater

April 8, 2026

Date: Sunday, May 17, 2026
Time: 11:30am – 12:30pm
Location: Innovation Theater 7, Exhibit Hall
Orange County Convention Center

Please join expert physician Cedric Jamie Rutland, MD, as he explores the data and use of JASCAYD® (nerandomilast) tablets. During this learning theater program, Dr. Rutland will review the results of the clinical trial and discuss the use of JASCAYD in appropriate patients.

This presentation is intended for US HCPs only. The FDA-approved indications for JASCAYD® are for the US and may or may not be approved in other jurisdictions. This program was developed by Boehringer Ingelheim Pharmaceuticals and is neither sponsored by nor endorsed by ATS and does not offer CME/CE credit. This evening symposium education program sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. Attendance is limited to healthcare professionals only. Aspects of this program may be reportable under the Physician Payments Sunshine Act. Registration not required. Spaces limited.

(04/26) EM-US-104630

Learn More

Share on social media